Clinical Trial Update: Effect of Microvesicles and Exosomes Therapy on β-cell Mass in Type I Diabetes Mellitus (T1DM) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on microvesicle and exosome therapy aimed at increasing beta-cell mass in Type 1 diabetes mellitus, currently in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Exosome therapy (microvesicle therapy)

Snippet

Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt | Conditions: Diabetes Mellitus Type 1 | Phase 2, Phase 3 | Status: UNKNOWN